Abstract
Large-scale chromatography operations continue to occupy a key position in the overall strategy for the downstream processing and purification of protein products for therapeutic use. Increasing product titres from mammalian cell culture has resulted in a trend to identify ways of improving the economics of product recovery and purification processes. In commercial manufacturing, a requirement exists to increase the scale of the chromatography operations, which are typically developed and optimised in small-scale experiments. This short review discusses the key factors in the chromatography process that need to be considered as the scale of the purification step is increased in order to maintain the purity and integrity of the product purified at smaller scale.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reichert, J. and Pavlou, A. (2004) Monoclonal antibodies market. Nature Reviews. Drug Discovery 3, 383–384.
Kretzmer, G. (2002) Industrial processes with animal cells. Applied Microbiology and Biotechnology 59, 135–142.
Wurm, F. (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnology 22, 1393–1398.
Moreira, A. R. (2007) The evolution of protein expression and cell culture. Biopharm International 20(10), 56–68.
Birch, J. R. and Racher, A. J. (2006) Antibody production. Advanced Drug Delivery Reviews 58, 671–685.
Langer, E. (2007) Dowstream production challenges in 2007. Bioprocess International 5(6), 22–28.
Low, D., O’Leary, R., and Pujar, N. S. (2007) Future of antibody purification. Journal of Chromatography B 848, 48–63.
Curling, J. and Gottschalk, U. (2007) Process chromatography: five decades of innovation. Biopharm International 20(10), 70–93.
Thommes, J. and Etzel, M. (2007) Alternatives to chromatographic separations. Biotechnology Progress 23, 42–45.
Sofer, G. and Chirica, L. C. (2007) Improving productivity in downstream processing. Pharmaceutical Technology Europe 19(4), 35–41.
Gottschalk, U. (2008) Bioseparation in antibody manufacturing: the good, the bad and the ugly. Biotechnology Progress 24, 496–503.
Sofer, G. (2005) Guidelines to process validation, in Process Validation in Manufacturing of Biopharmaceuticals (Rathore, A. S. and Sofer, G., ed.), CRC Press, Taylor and Francis Group, Florida.
Edwards, J. (1997) Large-scale column chromatography – a GMP manufacturing perspective, in Handbook of Downstream Processing (Goldberg, E., ed.), Blackie Academic & Professional, London, pp. 167–184.
O’Neil, P. and Sellick, I. (2004) Innovations that improve process column chromatography. Filtration and Separation 41, 24–27.
International Conference on Harmonisation (ICH) Topic Q7. (2000) Good manufacturing practice guide for active pharmaceutical ingredients, CPMP/ICH/4106/00.
Schellekens, H. (2002) Bioequivalence and the immunogenicity of biopharmaceuticals. Nature Reviews. Drug Discovery 1, 457–462.
Sofer, G. and Hagel, L. (1997) Purification design, optimisation and scale-up, in Handbook of Process Chromatography: A Guide to Optimisation, Scale-Up and Validation (Sofer, G. and Hagel, L., ed.), Academic Press, New York, pp. 27–113.
Rathore, A. and Velayudhan, A. (2003) Guidelines for optimisation and scale-up in preparative chromatography. Biopharm International 16(1), 34–42.
Janson, J. C. and Hedman, P. (1982) Large-scale chromatography of proteins, in Advances in Biochemical Engineering (Fiechter, A., ed.), Springer Verlag, Berlin, 25, pp. 43–99.
Aldington, S. and Bonnerjea, J. (2007) Scale-up of monoclonal antibody purification processes. Journal of Chromatography B 848, 64–78.
Graumann, K. and Ebenbichler, A.-A. (2005) Development and scale-up of preparative HIC for the purification of a recombinant therapeutic protein. Chemical Engineering and Technology 28, 1398–1406.
Ghose, S., Hubbard, B., and Cramer, S. M. (2006) Evaluation and comparison of alternatives to protein A chromatography, mimetic and hydrophobic charge induction chromatographic stationary phases. Journal of Chromatography A 1122, 144–152.
Bloomingburg, G. and Gandhi, P. (2005) Engineering design considerations for column packing in large-scale biotechnology facilities. Bioprocess International 3(6), 44–51.
Rathore, A. S., Kennedy, R. M., O’Donnell, K., Bemberis, I., and Kaltenbrunner, O. (2003) Qualification of a chromatographic column: why and how to do it? Biopharm International 16(3), 30–40.
Rathore, A. S. and Sofer, G. (2005) Life span studies for chromatography and filtration media, in Process Validation in Manufacturing of Biopharmaceuticals (Rathore, A. S. and Sofer, G., ed.), CRC Press, Taylor and Francis Group, Florida, pp. 169–203.
Sofer, G. and Yourkin, J. (2007) Cleaning and cleaning validation in process chromatography. Bioprocess International 5(10), 72–82.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Milne, J.J. (2011). Scale-Up of Protein Purification: Downstream Processing Issues. In: Walls, D., Loughran, S. (eds) Protein Chromatography. Methods in Molecular Biology, vol 681. Humana Press. https://doi.org/10.1007/978-1-60761-913-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-60761-913-0_5
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-912-3
Online ISBN: 978-1-60761-913-0
eBook Packages: Springer Protocols